-
Mashup Score: 4IASLC 50th Anniversary Book Pre-Order Interest Form - 1 day(s) ago
Please click the link to complete this form.
Source: form.jotform.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 42024 IASLC CT Screening Symposium | IASLC - 2 day(s) ago
The CT Screening Symposium is a 1-day, immersive, in-person event being featured at WCLC 2024 focused on lung cancer screening technologies and best practices. …
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet-
Register Now for the 2024 CT Screening Symposium: Forefront Advances in Lung Cancer Screening! A premier event featured @ #WCLC24, taking place in San Diego, CA, Sept. 7, & dedicated to advancing knowledge/practices in #lungcancer screening. https://t.co/ExsyHGeO44 #CTSS24 #LCSM https://t.co/n4gd5ThU2x
-
-
Mashup Score: 6National Cancer Plan - Everyone Has a Role - 3 day(s) ago
The National Cancer Plan provides a comprehensive framework for meaningful collaboration to change how we know cancer today.
Source: nationalcancerplan.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
The #NationalCancerPlan lays out 8 goals needed to reduce cancer mortality rate & transform the meaning of cancer diagnosis. The #IASLC supports research in all aspects of thoracic cancers worldwide. #Every1HasARole in the plan's success. #CancerMoonshot https://t.co/vZ2zrff5Tv https://t.co/rR0MwnRiA0
-
-
Mashup Score: 25IASLC's Time Capsule - Google Drive - 3 day(s) ago
No files in this folder. Sign in to add files to this
Source: drive.google.comCategories: General Medicine News, Onc News and JournalsTweet-
Over the last 50 years, the #IASLC has grown into a world-class, multidisciplinary & global thoracic cancer society. Share your memories with us as we celebrate this amazing journey! Upload pictures & more to the IASLC 50-Year Time Capsule here: https://t.co/6ioZoSOYjh #IASLC50 https://t.co/54rV2xpnQ4
-
-
Mashup Score: 9
Dr. Narjust Florez, Lung Cancer Considered Host, encourages members to participate in the first IASLC Global Membership Survey on Inclusivity. The 5-minute survey, is available in multiple languages and aims to understand the unique needs of each of our regions and those members. The data collected will be used to improve the organization’s diversity, equity, and inclusion efforts.
Source: voicesoftheiaslc.gv-one.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 24IASLC's Time Capsule - Google Drive - 8 day(s) ago
No files in this folder. Sign in to add files to this
Source: drive.google.comCategories: General Medicine News, Onc News and JournalsTweet-
Over the last 50 years, the #IASLC has grown into a world-class, multidisciplinary & global thoracic cancer society. Share your memories with us as we celebrate this amazing journey! Upload pictures & more to the IASLC 50-Year Time Capsule here: https://t.co/6ioZoSOYjh #IASLC50 https://t.co/54rV2xpnQ4
-
-
Mashup Score: 17FDA Approval: Adjuvant Alectinib for Resected NSCLC | IASLC - 9 day(s) ago
In the wake of the FDA’s approval of alectinib for resected non-small cell lung cancer, Lung Cancer Considered host Dr. Narjust Florez and Dr. Benjamen Solomo …
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 15Annual Report 2023 | IASLC - 10 day(s) ago
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1IASLC Launches Global Member Survey on Diversity, Equity, and Inclusion - ILCN.org (ILCN/WCLC) - 10 day(s) ago
The association seeks input from members to better understand the current DEI landscape so it can continue to build a diverse international community dedicated to the elimination of thoracic malignancies.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5US Food and Drug Administration Accepts New Drug Application for Ensartinib - ILCN.org (ILCN/WCLC) - 11 day(s) ago
The filing was based on results from a global phase III study designed to compare the ALK inhibitor to crizotinib in the first-line treatment of ALK-positive NSCLC.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
In 2024, the #IASLC celebrates its 50-year anniversary. You can remember this momentous occasion for years to come, with the special 50th Anniversary edition of our history book! Don't miss out, pre-order your copy of the book today: https://t.co/fC9kH25qds #LCSM #IASLC50 https://t.co/y57OmLdYB4